Psoriasis is a chronic inflammatory skin disease characterized by epidermal hyperproliferation, aberrant differentiation of keratinocytes, and dysregulated immune responses. WW domain-containing oxidoreductase (WWOX) is a non-classical tumor suppressor gene that regulates multiple cellular processes, including proliferation, apoptosis, and migration. This study aimed to explore the possible role of WWOX in the pathogenesis of psoriasis. Immunohistochemical analysis showed that the expression of WWOX was increased in epidermal keratinocytes of both human psoriatic lesions and imiquimod-induced mice psoriatic model. Immortalized human epidermal keratinocytes were transduced with a recombinant adenovirus expressing microRNA specific for WWOX to downregulate its expression. Inflammatory responses were detected using Western blotting, real-time quantitative reverse transcription polymerase chain reaction (PCR), and enzyme-linked immunosorbent assay. In human epidermal keratinocytes, WWOX knockdown reduced nuclear factor-kappa B signaling and levels of proinflammatory cytokines induced by polyinosinic: polycytidylic acid [(poly(I:C)] in vitro. Furthermore, calcium chelator and protein kinase C (PKC) inhibitors significantly reduced poly(I:C)-induced inflammatory reactions. WWOX plays a role in the inflammatory reaction of epidermal keratinocytes by regulating calcium and PKC signaling. Targeting WWOX could be a novel therapeutic approach for psoriasis in the future.
15 May 2023 in Biochemical and Biophysical Research Communications
Since the emergence of coronavirus disease 2019 (COVID-19), several reports have described various skin manifestations associated with COVID-19. Retiform purpura is a cutaneous manifestation that is likely associated with coagulopathy in patients with severe COVID-19. Here, we present the case of a 62-year-old man with hypertension and multiple myeloma who presented with retiform purpuric patches on both legs two days after a chemotherapy session with carfilzomib and dexamethasone. He had no other respiratory symptoms or fever; however, he was hospitalized for supportive care and underwent COVID-19 screening with reverse transcriptase polymerase chain reaction, which was positive. Histopathologic evaluation of the two punch biopsy samples obtained from the affected skin revealed perivascular lymphocytic lesions with fibrinoid degeneration, extravasated red blood cells, and fibrin deposition in the deep dermis. Based on these findings, the patient was diagnosed with COVID-19 and retiform purpura. He received intensive care after developing fever, cough, sputum production, and dyspnea. However, the patient developed multifocal cerebral infarctions and eventually died. Dermatologists should recognize retiform purpura, which may appear before other COVID-19 symptoms, as an alarm sign which can aid in the prompt implementation of appropriate treatment.